Active Motif
Patricia F. has a diverse work experience in various roles within the sales and account management field. Patricia started their career in 1995 as a Referral Associate/Sales Associate at Weichert Realtors. In 1995, they moved on to become a Senior Sales Representative at Life Tech (formerly Perseptive Biosystems) and held this position until 2000. From 2000 to 2005, they worked at Promega as a Key Account Manager/Regional Business Development Manager. Then, they held the role of Senior Account Executive - Biacore at GE Healthcare from 2005 to 2007. In 2007, they became a Sales Manager - Central East at ForteBio but transitioned to HTG Molecular Diagnostics in 2008 as a Senior Corporate Account Executive. Patricia then joined Cell Signaling Technology in 2010 as a Senior Account Manager until 2014. From 2012 to 2015, they served as a Business Development Advisor at One World Lab, Inc. Patricia moved on to Enzo Life Sciences, Inc. in 2015 and worked there as a Senior Account Manager until 2016. Patricia'smost recent positions include Key Account Manager from 2016 to 2019 and Senior Key Account Manager from 2019 onwards at Active Motif.
Patricia F. pursued their education in a diligent and systematic manner. Starting in 1974, they attended Paul VI Regional High School, where they completed their College Prep studies and earned their High School Diploma in 1978. Subsequently, from 1978 to 1982, Patricia attended Fairfield University, where they obtained a Bachelor of Science (BS) degree. Patricia'smajor was Biology, and they chose Modern Languages as their minor field of study. After a significant gap in their educational timeline, Patricia joined Montclair State University in 2014 and completed their Master of Science (M.S.) degree in Molecular Biology in 2026. No information is provided regarding their earlier education at St Clare's Grammar School.
This person is not in any offices
Active Motif
3 followers
At Active Motif, they believe that knowledge of the epigenome will be key in the development of precision medicine. For that reason, they are committed to developing the best tools and techniques to help researchers elucidate how epigenetic mechanisms impact the genome, transcriptome, and proteome through gene regulation.